Danco Laboratories, LLC is a privately held women’s health pharmaceutical company formed specifically to bring Mifeprex® (mifepristone), the first FDA-approved non-surgical option for ending early pregnancy, to the US. Mifeprex® has been used by more than 4 Million women in the US.